Bahare Abdollahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bahare Abdollahi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Zahra Noorani Mejareh
Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications Afsaneh Dehnad
School of Health Management and Information Sciences, Tehran, Iran
1 shared publicationAhmad Ghashghaee
Social Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication- Ali Kabir
Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Alireza Gandomi-Mohammadabadi
Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Ehsan Bitaraf
Center for Technology and Innovation in Cardiovascular Informatics, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 9 February 2022
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 8, 100326
The global Prevalence of Depression among Health Workers during the COVID-19 pandemic: a Systematic review and Meta-analysis
- 9 February 2022
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 8, 100326
Open AccessThe global Prevalence of Depression among Health Workers during the COVID-19 pandemic: a Systematic review and Meta-analysis
- Open Access
- 2 July 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-21
Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death (
- 2 July 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-21
Open AccessEffects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study
Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death (